Literature DB >> 6328662

Immunoregulatory lymphokines of T hybridomas from AIDS patients: constitutive and inducible suppressor factors.

J Laurence, L Mayer.   

Abstract

Supernatants derived from peripheral blood mononuclear cell cultures of certain patients with the acquired immunodeficiency syndrome (AIDS) or its prodromes have the capacity to block T cell-dependent immune reactivity in vitro. T cells derived from a patient positive for antibody to the lymphadenopathy associated virus ( LAV ), and elaborating high titers of these soluble suppressor factors, were fused to a mutagenized clone of the human T lymphoblastoid cell line KE37 . Molecules capable of profoundly depressing T cell-dependent polyclonal antibody production and DNA synthetic responses, either directly or after incubation with normal adherent cells, were isolated from stable hybrid clones.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6328662     DOI: 10.1126/science.6328662

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  16 in total

Review 1.  Retrovirus and filovirus "immunosuppressive motif" and the evolution of virus pathogenicity in HIV-1, HIV-2, and Ebola viruses.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

2.  Impairment in T-lymphocyte responses during early infection with the human immunodeficiency virus.

Authors:  J Bentin; C D Tsoukas; J A McCutchan; S A Spector; D D Richman; J H Vaughan
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

3.  PolyI.polyC12U-mediated inhibition of loss of alloantigen responsiveness viral replication in human CD4+ T cell clones exposed to human immunodeficiency virus in vitro.

Authors:  J Laurence; J Kulkosky; S M Friedman; D N Posnett; P O Ts'o
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

4.  Opportunistic infections in acquired immune deficiency syndrome result from synergistic defects of both the natural and adaptive components of cellular immunity.

Authors:  F P Siegal; C Lopez; P A Fitzgerald; K Shah; P Baron; I Z Leiderman; D Imperato; S Landesman
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

5.  Pneumocystis carinii pneumonia in the acquired immune deficiency syndrome: response to inadvertent steroid therapy.

Authors:  D K MacFadden; J D Edelson; A S Rebuck
Journal:  Can Med Assoc J       Date:  1985-05-15       Impact factor: 8.262

6.  Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals.

Authors:  M Clerici; F T Hakim; D J Venzon; S Blatt; C W Hendrix; T A Wynn; G M Shearer
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

7.  Subcutaneous fibromatosis associated with an acquired immune deficiency syndrome in pig-tailed macaques.

Authors:  C C Tsai; T F Warner; H Uno; W E Giddens; H D Ochs
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

8.  A factor from CD8 cells of human immunodeficiency virus-infected patients suppresses HLA self-restricted T helper cell responses.

Authors:  M Clerici; E Roilides; C S Via; P A Pizzo; G M Shearer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

9.  Biological and biochemical characterization of a factor produced spontaneously by adherent cells of human immunodeficiency virus-infected patients inhibiting interleukin-2 receptor alpha chain (Tac) expression on normal T cells.

Authors:  A Ammar; C Cibert; A M Bertoli; V Tsilivakos; C Jasmin; V Georgoulias
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

10.  Identification of a novel cell-type and context specific enhancer within the negative regulatory element of the human immunodeficiency virus type 1 long terminal repeat.

Authors:  S K Sikder; D Mitra; J Laurence
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.